TOKYO (Reuters) - U.S. private equity firm Bain Capital said on Monday it will not launch a tender offer for Fuji Soft, ...

Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

including managing lender relationships and working with the investment teams on the capital structure for both acquisition financing and refinancing. Alternatives firm Bain, which has $185 ...

Firms are aiming to announce an agreement as soon as Friday Potential deal would add to ongoing dealmaking boom in Japan Bain Capital is nearing a deal ... pharmaceutical company after outbidding ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

Investment to accelerate Milacron’s growth ... of driving innovation in plastics," said Matt Evans, a Partner at Bain Capital Special Situations. "With manufacturers increasingly focused on ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment ...

Investment to accelerate Milacron’s growth and strengthen ... with a 50-year legacy of driving innovation in plastics," said Matt Evans, a Partner at Bain Capital Special Situations. "With ...